Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0103 USD | -10.43% | +3.00% | -94.72% |
Mar. 21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
Mar. 20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | 3.8M | Capitalization | 627K |
---|---|---|---|---|---|
Net income 2023 * | -28M | Net income 2024 * | -47M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.16 x |
P/E ratio 2023 * |
-0.01
x | P/E ratio 2024 * |
-0.01
x | Employees | 54 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 46.66% |
Latest transcript on Better Therapeutics, Inc.
1 day | -10.43% | ||
1 week | +3.00% | ||
Current month | -20.77% | ||
1 month | -6.36% | ||
3 months | -93.94% | ||
6 months | -93.18% | ||
Current year | -94.72% |
Managers | Title | Age | Since |
---|---|---|---|
Andres Camacho
CTO | Chief Tech/Sci/R&D Officer | - | - |
Leslie Miller
AUD | Comptroller/Controller/Auditor | 43 | 21-09-30 |
Corporate Officer/Principal | - | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.0103 | -10.43% | 37 282 |
24-05-09 | 0.0115 | +27.07% | 77,825 |
24-05-08 | 0.00905 | -9.50% | 109,695 |
24-05-07 | 0.01 | -14.53% | 545,850 |
24-05-06 | 0.0117 | +17.00% | 114,573 |
Delayed Quote OTC Markets, May 10, 2024 at 11:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.72% | 627K | |
+19.16% | 47.02B | |
+48.77% | 41.86B | |
+0.18% | 41.76B | |
-4.27% | 28.8B | |
+11.58% | 26.05B | |
-22.10% | 19.15B | |
+4.12% | 12.55B | |
+29.33% | 12.34B | |
-4.50% | 11.82B |
- Stock Market
- Equities
- BTTX Stock